Lucida Medical appoints Chief Operating Officer to drive global growth
Lucida Medical, a Cambridge University spin off advancing the prostate cancer pathway through AI, announces the appointment of Robin Barclay as Chief Operating Officer.
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
Building on June's momentum: Cross-organisation Mental Health Training is back
After the success of Promote Mental Health's open Mental Health First Aid Training course in June, we are running another course. Join us on 28th and 30th September for an enriched learning experience bringing together different organisations and roles.
Summer offer from Hinxton Hall Conference Centre
Whether you're planning for Q4, hosting a team away day, delivering training, or running a workshop, Hinxton Hall offers the ideal setting for productive meetings in beautiful surroundings.
Yu Sun joins Salus Wellness
We are very pleased to announce that Yu Sun has joined Salus Wellness this month.
Cambridge Forum announces world-class speaker line-up for AI & Health Conference
Cambridge Forum is delighted to announce a line-up of eminent speakers for its Tech for Good: AI and Health event, taking place on 10th and 11th September at Cambridge Corn Exchange.
Polygenic scores and public health services: moving the debate forward
New report from PHG Foundation is designed to help those making and shaping decisions around when and how polygenic scores could be implemented within publicly funded initiatives and specifically in the English NHS. The report draws on the insights of participants at a recent PHG-convened roundtable meeting, as well as our extensive research into the question of what polygenic scores can tell us…
EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy
ClearPoint Neuro’s system enables precise delivery to the seizure focus, ensuring best possible efficacy and safety of EpilepsyGTx’s investigational gene therapyPartnership will support first-in-human Phase 1/2a clinical trials of EPY201 in patients with focal refractor
DDW introduces new series of events aimed at connecting innovation with investment in early-stage drug discovery
Three-part event series will comprise a digital forum (30th September 2026), and two in-person events (London, UK, 4th November 2026, and Basel, Switzerland, March 2027)Focused on technology, innovation, and investment in early-stage drug discovery
Camena Bioscience appoints Gregory P. McGuinness as CEO
Internationally recognised business executive with extensive operational experience in life sciences, diagnostics and pharma Appointment will lead strategic growth plans, including commercialisation of the gSynth® platform for AI-driven antibody discover
Novogene Europe launches Untargeted Metabolomics Service at Cambridge Omics Centre
• Strengthens multiomics portfolio offering metabolite-level insight to connect molecular data with biological function across broader life science studies • New workflow built around Thermo Scientific Vanquish UHPLC coupled with Orbitrap Exploris 120 high-resolution accurate-mass mass spectrometry
New genomic method to track disease outbreaks globally
Phylo-Plex, a new computational method, has been developed by Wellcome Sanger Institute scientists and their collaborators to allow cost-effective and scalable DNA sequencing of pathogens in laboratories with limited resources.
G’s Fresh backs Cambridge Air Base Appeal
East Anglian Air Ambulance is pleased to announce that G’s Fresh – one of Europe’s leading fresh produce companies – is backing its Cambridge Air Base Appeal.
Eppendorf Focuses Outreach Programmes to Advance STEM Education in Europe
Hamburg, DE, 07 JULY 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to address
Bio-Rad Launches Vericheck ddPCR Kits Compatible with QX700 Platform for Biopharma Quality Control and Cell and Gene Therapy Workflows
New Vericheck ddPCR™ Kits Combine Highly Specific and Highly Sensitive DNA Detection and Quantification with the QX700™ System’s Seven-Color Multiplexing, Simplified Workflow, and Scalable Throughput
Novartis nominated for UX Design Award with Team Consulting
Novartis has been nominated for a UX Design Award for a new drug delivery digital onboarding experience, developed in collaboration with Team Consulting. Designed to support patients with relapsing forms of multiple sclerosis (RMS) in learning to self-inject, the digital platform has been nominated in recognition of its user-centred design to help patients manage their treatment safely and…
Cambridge scientist wins Lister Prize for pioneering Parkinson’s research project – backed by Addenbrooke’s Charitable Trust
A scientist whose pioneering Parkinson’s research was given early backing by Addenbrooke’s Charitable Trust (ACT) has just been awarded a prestigious Lister Prize Fellowship.
Deloitte digital consumer trends: over a third of consumers believe GenAI health advice is always accurate
A quarter of GenAI users have used the tool for advice about health or personal problemsHuman interaction in customer service is still the preference for consumers Four in five (81%) UK consumers don’t want AI to replace actors in film and TVA quarter (26%
Beyond capability: The questions I’m hearing
By Lily Lin, CEO of Excellence First Enterprise Consultancy.
Problems with cell’s ‘plumbing’ linked to signalling issues in neurodegenerative conditions
New research led by Prof Edward Avezov (UK DRI at Cambridge) reveals how the architecture of the cell’s transport network, the endoplasmic reticulum, can go awry and lead to problems with signalling in brain cells in conditions like Alzheimer’s.
Crossing the Blood-Brain Barrier: Why Natural Transport Mechanisms Are the Smarter Route
Most biologics and even small molecules fail to cross the blood-brain barrier, leaving CNS drug delivery a persistent bottleneck. Isogenica's latest short video looks at why researchers are turning to the brain's own transport systems as a more promising path in.
Solving LNP's Liver Problem: Why Targeting Is the Next Frontier in RNA Delivery
Lipid nanoparticles have powered the RNA medicine revolution, but their default tendency to accumulate in the liver limits use beyond hepatic disease.
Exonate appoints Olav Hellebø as Chief Executive Officer
Appointment of experienced executive forms part of the Company’s strategy to build momentum across its proprietary platform and therapeutic programs targeting retinal diseasesCompany is preparing a Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disea
Precision matters: Guardtech and DryR leading the way for controlled environment provision when things get seriously tight
East Anglian contamination control specialists Guardtech are collaborating with dry room experts DryR to strengthen their overall delivery of advanced cleanroom and dry room facilities across a wide range of high-tech sectors